LRRK2 and Parkinson disease: Thus, our study is the first to evaluate the effects of homotaurine on osteogenic differentiation, highlighting its potential implications for patients with Parkinson’s disease, particularly those with LRRK2 mutations, who often experience compromised bone homeostasis [51].